Search research articles
Contact Us
Filters
Showing results (91-100 of 159) with videos related to
Page
of 16
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society
|
January 7, 2005
Comparison of the effects of a distal embolic protection device and an aspiration catheter during percutaneous coronary intervention in patients with acute myocardial infarction
Isao Taguchi, Tomoaki Kanaya, Toru Toi, et al.
Journal of Cardiology
|
November 1, 2019
Atrial reverse remodeling represented by the atrial conduction time in persistent atrial fibrillation patients after catheter ablation: its impact on predicting late atrial fibrillation recurrence
Yuichi Hori, Shiro Nakahara, Reiko Fukuda, et al.
Heart and Vessels
|
May 21, 2017
Comparison of echocardiographic parameters to assess right ventricular function in pulmonary hypertension
Hirohisa Amano, Shichiro Abe, Suguru Hirose, et al.
International Journal of Cardiology
|
October 8, 2017
Myeloid-related protein-8/14 in acute coronary syndrome
Masashi Sakuma, Atsushi Tanaka, Norihiko Kotooka, et al.
European Journal of Medical Research
|
July 17, 2023
Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA)
Atsushi Tanaka, Isao Taguchi, Itaru Hisauchi, et al.
Reviews in Cardiovascular Medicine
|
July 30, 2024
Current Balloon Devices for Ablation of Atrial Fibrillation
Shiro Nakahara, Yuichi Hori, Reiko Fukuda, et al.
Cardiovascular Diabetology
|
May 2, 2025
Impact of baseline left ventricular ejection fraction and body mass index on the effect of 24-week Ipragliflozin treatment on left ventricular diastolic function in patients with type 2 diabetes and chronic kidney disease: insights from the PROCEED trial
Hiroki Teragawa, Atsushi Tanaka, Kanae Takahashi, et al.
Cardiovascular Diabetology
|
June 29, 2021
Reduction of estimated fluid volumes following initiation of empagliflozin in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the placebo-controlled, randomized EMBLEM trial
Atsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, et al.
Cardiovascular Diabetology
|
August 1, 2021
Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metformin
Atsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, et al.
Internal Medicine (Tokyo, Japan)
|
June 16, 2011
Potential benefit of statin therapy for dyslipidemia with chronic kidney disease: Fluvastatin Renal Evaluation Trial (FRET)
Teruo Inoue, Hideo Ikeda, Tsukasa Nakamura, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 159) with videos related to
Sort By:
Page
of 16
Circulation Journal : Official Journal of the Japanese Circulation Society
|
January 7, 2005
Comparison of the effects of a distal embolic protection device and an aspiration catheter during percutaneous coronary intervention in patients with acute myocardial infarction
Isao Taguchi, Tomoaki Kanaya, Toru Toi, et al.
Journal of Cardiology
|
November 1, 2019
Atrial reverse remodeling represented by the atrial conduction time in persistent atrial fibrillation patients after catheter ablation: its impact on predicting late atrial fibrillation recurrence
Yuichi Hori, Shiro Nakahara, Reiko Fukuda, et al.
Heart and Vessels
|
May 21, 2017
Comparison of echocardiographic parameters to assess right ventricular function in pulmonary hypertension
Hirohisa Amano, Shichiro Abe, Suguru Hirose, et al.
International Journal of Cardiology
|
October 8, 2017
Myeloid-related protein-8/14 in acute coronary syndrome
Masashi Sakuma, Atsushi Tanaka, Norihiko Kotooka, et al.
European Journal of Medical Research
|
July 17, 2023
Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA)
Atsushi Tanaka, Isao Taguchi, Itaru Hisauchi, et al.
Reviews in Cardiovascular Medicine
|
July 30, 2024
Current Balloon Devices for Ablation of Atrial Fibrillation
Shiro Nakahara, Yuichi Hori, Reiko Fukuda, et al.
Cardiovascular Diabetology
|
May 2, 2025
Impact of baseline left ventricular ejection fraction and body mass index on the effect of 24-week Ipragliflozin treatment on left ventricular diastolic function in patients with type 2 diabetes and chronic kidney disease: insights from the PROCEED trial
Hiroki Teragawa, Atsushi Tanaka, Kanae Takahashi, et al.
Cardiovascular Diabetology
|
June 29, 2021
Reduction of estimated fluid volumes following initiation of empagliflozin in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the placebo-controlled, randomized EMBLEM trial
Atsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, et al.
Cardiovascular Diabetology
|
August 1, 2021
Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metformin
Atsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, et al.
Internal Medicine (Tokyo, Japan)
|
June 16, 2011
Potential benefit of statin therapy for dyslipidemia with chronic kidney disease: Fluvastatin Renal Evaluation Trial (FRET)
Teruo Inoue, Hideo Ikeda, Tsukasa Nakamura, et al.
Page
of 16